(GIS) General Mills - Overview
Sector: Consumer DefensiveIndustry: Packaged Foods | Exchange NYSE (USA) | Currency USD | Market Cap: 19.935m | Total Return -36% in 12m
Stock: Cereal, Snacks, Baking Mixes, Yogurt, Pet Food
Total Rating 35
Risk 74
Buy Signal -1.78
| Risk 5d forecast | |
|---|---|
| Volatility | 22.4% |
| Relative Tail Risk | 2.14% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.94 |
| Alpha | -38.56 |
| Character TTM | |
|---|---|
| Beta | -0.026 |
| Beta Downside | -0.432 |
| Drawdowns 3y | |
|---|---|
| Max DD | 55.54% |
| CAGR/Max DD | -0.40 |
EPS (Earnings per Share)
Revenue
Description: GIS General Mills March 06, 2026
General Mills, Inc. (GIS) is a U.S.-based company manufacturing and marketing branded consumer foods globally. The company operates across four segments: North America Retail, International, North America Pet, and North America Foodservice. The packaged foods and meats sector is characterized by intense competition and reliance on brand recognition.
Its product portfolio includes a wide array of items such as cereals, yogurts, baking mixes, frozen foods, and snacks. General Mills also produces pet food and operates ice cream parlors. The company utilizes a diversified distribution model, selling to various retailers, foodservice providers, and e-commerce platforms. This multi-channel approach is common for established consumer goods companies seeking broad market penetration.
General Mills markets its products under numerous well-known brands, including Cheerios, Häagen-Dazs, and Blue Buffalo. Understanding the full scope of their brand portfolio can provide deeper insights into their market positioning. For a comprehensive analysis of GISs financial performance and market data, consider exploring ValueRay.
Headlines to watch out for
- Pet food sales growth boosts North America Retail segment
- Commodity price volatility impacts production costs
- International segment currency fluctuations affect revenue
- North America Foodservice demand sensitive to economic conditions
- Consumer health trends shift demand for branded foods
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 2.21b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA -2.48 > 1.0 |
| NWC/Revenue: -20.67% < 20% (prev -13.34%; Δ -7.33% < -1%) |
| CFO/TA 0.07 > 3% & CFO 2.23b > Net Income 2.21b |
| Net Debt (13.18b) to EBITDA (3.05b): 4.32 < 3 |
| Current Ratio: 0.56 > 1.5 & < 3 |
| Outstanding Shares: last quarter (542.5m) vs 12m ago -2.25% < -2% |
| Gross Margin: 32.97% > 18% (prev 0.35%; Δ 3.26k% > 0.5%) |
| Asset Turnover: 56.43% > 50% (prev 60.06%; Δ -3.63% > 0%) |
| Interest Coverage Ratio: 3.98 > 6 (EBITDA TTM 3.05b / Interest Expense TTM 525.9m) |
Altman Z'' 2.84
| A: -0.12 (Total Current Assets 4.89b - Total Current Liabilities 8.69b) / Total Assets 32.40b |
| B: 0.70 (Retained Earnings 22.53b / Total Assets 32.40b) |
| C: 0.06 (EBIT TTM 2.09b / Avg Total Assets 32.55b) |
| D: 0.87 (Book Value of Equity 20.06b / Total Liabilities 23.05b) |
| Altman-Z'' Score: 2.84 = A |
Beneish M -2.91
| DSRI: 1.11 (Receivables 1.86b/1.79b, Revenue 18.37b/19.64b) |
| GMI: 1.07 (GM 32.97% / 35.37%) |
| AQI: 1.01 (AQ_t 0.74 / AQ_t-1 0.73) |
| SGI: 0.94 (Revenue 18.37b / 19.64b) |
| TATA: -0.00 (NI 2.21b - CFO 2.23b) / TA 32.40b) |
| Beneish M-Score: -2.91 (Cap -4..+1) = A |
What is the price of GIS shares?
As of March 27, 2026, the stock is trading at USD 36.02 with a total of 11,741,718 shares traded.
Over the past week, the price has changed by -3.95%, over one month by -19.83%, over three months by -22.36% and over the past year by -35.97%.
Over the past week, the price has changed by -3.95%, over one month by -19.83%, over three months by -22.36% and over the past year by -35.97%.
Is GIS a buy, sell or hold?
General Mills has received a consensus analysts rating of 3.09.
Therefor, it is recommend to hold GIS.
- StrongBuy: 2
- Buy: 2
- Hold: 17
- Sell: 0
- StrongSell: 2
What are the forecasts/targets for the GIS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 41.6 | 15.6% |
| Analysts Target Price | 41.6 | 15.6% |
GIS Fundamental Data Overview March 24, 2026
P/E Trailing = 8.0344
P/E Forward = 10.8578
P/S = 1.0851
P/B = 2.1197
P/EG = 11.7371
Revenue TTM = 18.37b USD
EBIT TTM = 2.09b USD
EBITDA TTM = 3.05b USD
Long Term Debt = 10.99b USD (from longTermDebt, last quarter)
Short Term Debt = 2.98b USD (from shortTermDebt, last quarter)
Debt = 13.97b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 13.18b USD (from netDebt column, last quarter)
Enterprise Value = 33.12b USD (19.93b + Debt 13.97b - CCE 785.5m)
Interest Coverage Ratio = 3.98 (Ebit TTM 2.09b / Interest Expense TTM 525.9m)
EV/FCF = 20.07x (Enterprise Value 33.12b / FCF TTM 1.65b)
FCF Yield = 4.98% (FCF TTM 1.65b / Enterprise Value 33.12b)
FCF Margin = 8.98% (FCF TTM 1.65b / Revenue TTM 18.37b)
Net Margin = 12.05% (Net Income TTM 2.21b / Revenue TTM 18.37b)
Gross Margin = 32.97% ((Revenue TTM 18.37b - Cost of Revenue TTM 12.31b) / Revenue TTM)
Gross Margin QoQ = 30.61% (prev 34.82%)
Tobins Q-Ratio = 1.02 (Enterprise Value 33.12b / Total Assets 32.40b)
Interest Expense / Debt = 0.92% (Interest Expense 128.4m / Debt 13.97b)
Taxrate = 24.64% (99.9m / 405.4m)
NOPAT = 1.58b (EBIT 2.09b * (1 - 24.64%))
Current Ratio = 0.56 (Total Current Assets 4.89b / Total Current Liabilities 8.69b)
Debt / Equity = 1.49 (Debt 13.97b / totalStockholderEquity, last quarter 9.34b)
Debt / EBITDA = 4.32 (Net Debt 13.18b / EBITDA 3.05b)
Debt / FCF = 7.99 (Net Debt 13.18b / FCF TTM 1.65b)
Total Stockholder Equity = 9.34b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.80% (Net Income 2.21b / Total Assets 32.40b)
RoE = 23.70% (Net Income TTM 2.21b / Total Stockholder Equity 9.34b)
RoCE = 10.29% (EBIT 2.09b / Capital Employed (Equity 9.34b + L.T.Debt 10.99b))
RoIC = 6.68% (NOPAT 1.58b / Invested Capital 23.59b)
WACC = 3.75% (E(19.93b)/V(33.90b) * Re(5.89%) + D(13.97b)/V(33.90b) * Rd(0.92%) * (1-Tc(0.25)))
Discount Rate = 5.89% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares Correlation 3-Years: -81.65 | Cagr: -1.61%
[DCF] Terminal Value 85.65% ; FCFF base≈1.98b ; Y1≈1.85b ; Y5≈1.72b
[DCF] Fair Price = 72.03 (EV 51.62b - Net Debt 13.18b = Equity 38.44b / Shares 533.6m; r=6.0% [WACC]; 5y FCF grow -8.17% → 3.0% )
EPS Correlation: -61.50 | EPS CAGR: -13.86% | SUE: -0.70 | # QB: 0
Revenue Correlation: -53.30 | Revenue CAGR: -2.57% | SUE: 0.00 | # QB: 0
EPS next Quarter (2026-08-31): EPS=0.82 | Chg7d=-0.044 | Chg30d=-0.082 | Revisions Net=-9 | Analysts=12
EPS current Year (2026-05-31): EPS=3.42 | Chg7d=-0.075 | Chg30d=-0.135 | Revisions Net=-17 | Growth EPS=-18.7% | Growth Revenue=-5.5%
EPS next Year (2027-05-31): EPS=3.33 | Chg7d=-0.137 | Chg30d=-0.237 | Revisions Net=-17 | Growth EPS=-2.8% | Growth Revenue=-2.4%
[Analyst] Revisions Ratio: -1.00 (0 Up / 9 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -4.5% (Discount Rate 7.9% - Earnings Yield 12.4%)
[Growth] Growth Spread = +1.7% (Analyst -2.9% - Implied -4.5%)
P/E Forward = 10.8578
P/S = 1.0851
P/B = 2.1197
P/EG = 11.7371
Revenue TTM = 18.37b USD
EBIT TTM = 2.09b USD
EBITDA TTM = 3.05b USD
Long Term Debt = 10.99b USD (from longTermDebt, last quarter)
Short Term Debt = 2.98b USD (from shortTermDebt, last quarter)
Debt = 13.97b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 13.18b USD (from netDebt column, last quarter)
Enterprise Value = 33.12b USD (19.93b + Debt 13.97b - CCE 785.5m)
Interest Coverage Ratio = 3.98 (Ebit TTM 2.09b / Interest Expense TTM 525.9m)
EV/FCF = 20.07x (Enterprise Value 33.12b / FCF TTM 1.65b)
FCF Yield = 4.98% (FCF TTM 1.65b / Enterprise Value 33.12b)
FCF Margin = 8.98% (FCF TTM 1.65b / Revenue TTM 18.37b)
Net Margin = 12.05% (Net Income TTM 2.21b / Revenue TTM 18.37b)
Gross Margin = 32.97% ((Revenue TTM 18.37b - Cost of Revenue TTM 12.31b) / Revenue TTM)
Gross Margin QoQ = 30.61% (prev 34.82%)
Tobins Q-Ratio = 1.02 (Enterprise Value 33.12b / Total Assets 32.40b)
Interest Expense / Debt = 0.92% (Interest Expense 128.4m / Debt 13.97b)
Taxrate = 24.64% (99.9m / 405.4m)
NOPAT = 1.58b (EBIT 2.09b * (1 - 24.64%))
Current Ratio = 0.56 (Total Current Assets 4.89b / Total Current Liabilities 8.69b)
Debt / Equity = 1.49 (Debt 13.97b / totalStockholderEquity, last quarter 9.34b)
Debt / EBITDA = 4.32 (Net Debt 13.18b / EBITDA 3.05b)
Debt / FCF = 7.99 (Net Debt 13.18b / FCF TTM 1.65b)
Total Stockholder Equity = 9.34b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.80% (Net Income 2.21b / Total Assets 32.40b)
RoE = 23.70% (Net Income TTM 2.21b / Total Stockholder Equity 9.34b)
RoCE = 10.29% (EBIT 2.09b / Capital Employed (Equity 9.34b + L.T.Debt 10.99b))
RoIC = 6.68% (NOPAT 1.58b / Invested Capital 23.59b)
WACC = 3.75% (E(19.93b)/V(33.90b) * Re(5.89%) + D(13.97b)/V(33.90b) * Rd(0.92%) * (1-Tc(0.25)))
Discount Rate = 5.89% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares Correlation 3-Years: -81.65 | Cagr: -1.61%
[DCF] Terminal Value 85.65% ; FCFF base≈1.98b ; Y1≈1.85b ; Y5≈1.72b
[DCF] Fair Price = 72.03 (EV 51.62b - Net Debt 13.18b = Equity 38.44b / Shares 533.6m; r=6.0% [WACC]; 5y FCF grow -8.17% → 3.0% )
EPS Correlation: -61.50 | EPS CAGR: -13.86% | SUE: -0.70 | # QB: 0
Revenue Correlation: -53.30 | Revenue CAGR: -2.57% | SUE: 0.00 | # QB: 0
EPS next Quarter (2026-08-31): EPS=0.82 | Chg7d=-0.044 | Chg30d=-0.082 | Revisions Net=-9 | Analysts=12
EPS current Year (2026-05-31): EPS=3.42 | Chg7d=-0.075 | Chg30d=-0.135 | Revisions Net=-17 | Growth EPS=-18.7% | Growth Revenue=-5.5%
EPS next Year (2027-05-31): EPS=3.33 | Chg7d=-0.137 | Chg30d=-0.237 | Revisions Net=-17 | Growth EPS=-2.8% | Growth Revenue=-2.4%
[Analyst] Revisions Ratio: -1.00 (0 Up / 9 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -4.5% (Discount Rate 7.9% - Earnings Yield 12.4%)
[Growth] Growth Spread = +1.7% (Analyst -2.9% - Implied -4.5%)